Johns Hopkins University
Baltimore, Maryland, United States
Dr. Julie J. Paik is an Associate Professor of Medicine in the Division of Rheumatology at the Johns Hopkins University School of Medicine. She is the Co-Director of the Johns Hopkins Myositis Center and also acts as the Director of Clinical Trials at the Johns Hopkins Myositis Center. Her areas of research focus are in novel therapeutics in myositis, overlap myositis with scleroderma, and myocarditis in myositis.
Dr. Paik served as the principal investigator of the first proof of concept clinical trial of tofacitinib in adult dermatomyositis (STIR) that has led to further studies in the use of JAK inhibitors in the treatment of dermatomyositis.
Dr. Paik is also serves as the principal investigator of a large multi-investigator funded UM1 NIAID Hopkins Autoimmunity Center of Excellence.
She is also dedicated to patient advocacy and education in myositis and serves as the Vice-Chair of the TMA (The Myositis Association) Medical Advisory Board.
Saturday, October 25, 2025
7:30 AM – 9:55 AM Central Time
Disclosure(s): ArgenX: Grant/Research Support (Ongoing); Priovant: Grant/Research Support (Ongoing)
Saturday, October 25, 2025
10:35 AM – 1:00 PM Central Time
Disclosure(s): ArgenX: Grant/Research Support (Ongoing); Priovant: Grant/Research Support (Ongoing)
Management of Challenging Cases in Myositis
Sunday, October 26, 2025
9:00 AM – 10:30 AM Central Time
Disclosure(s): ArgenX: Grant/Research Support (Ongoing); Priovant: Grant/Research Support (Ongoing)
Strengthening Our Understanding of Less Common Forms of Inflammatory Myopathies
Monday, October 27, 2025
8:30 AM – 9:30 AM Central Time
Disclosure(s): ArgenX: Grant/Research Support (Ongoing); Priovant: Grant/Research Support (Ongoing)
Getting to the Heart of the Issue: Perimyocarditis in Autoimmune Diseases
Tuesday, October 28, 2025
1:00 PM – 2:00 PM Central Time
Disclosure(s): ArgenX: Grant/Research Support (Ongoing); Priovant: Grant/Research Support (Ongoing)
Case Presentations on Lupus and Myositis
Tuesday, October 28, 2025
1:40 PM – 2:00 PM Central Time
Disclosure(s): ArgenX: Grant/Research Support (Ongoing); Priovant: Grant/Research Support (Ongoing)